SNHG16 was expressed at a lower level in the cancerous tissue than normal tissue, and SNHG16 could alleviate 5‐FU resistance.97 Liu J et al showed that SNHG20 played an oncogenic role in liver cancer, and promoted the EMT pathway in cancer progression.98 The gene discussed is SNHG16; the disease is liver cancer.